lycorine has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cong, X; He, Y; Hu, M; Liu, M; Peng, S; Qin, M; Xing, Y; Yi, Z | 1 |
| He, P; Huang, A; Lan, L; Xing, Y; Yi, Z; Ying, X | 1 |
2 other study(ies) available for lycorine and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer.
Topics: Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Phenanthridines; Prostatic Neoplasms; Signal Transduction; STAT3 Transcription Factor; Transplantation, Heterologous | 2015 |
Lycorine inhibits breast cancer growth and metastasis via inducing apoptosis and blocking Src/FAK-involved pathway.
Topics: Amaryllidaceae Alkaloids; Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Phenanthridines; Signal Transduction; src-Family Kinases; Xenograft Model Antitumor Assays | 2017 |